Industry NewsMicrofluidics enables reliable siRNA drug delivery for inflammatory diseases and tumor targeting
Industry NewsAbivax announces German regulatory approval of ABX464 Covid-19 Phase 2b/3 clinical trial
Industry NewsFirst results from human COVID-19 immunology study reveal universally effective antibodies
Expert InsightsPancreatic cancer-derived organoids and multimodal plate imaging to predict drug responses